Axon Therapeutics
San Diego, US · Founded 2022 · Delaware corporation
Founders & leadership
DC
David c DodickNamed on SEC filing
PR
Pierre RiviereNamed on SEC filing
FP
Frank PorrecaNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$5M disclosed across 1 round · 2022
▶$5MraisedAug 2022 · 2 investors · BiotechnologyRule 506(b)
▶$5MraisedAug 2022 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David c DodickDirector
- Pierre RiviereExecutive Officer, Director
- Frank PorrecaDirector
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Axon Therapeutics raised?
- Axon Therapeutics has disclosed $5M raised across 1 round.
- Where is Axon Therapeutics headquartered?
- Axon Therapeutics is headquartered in San Diego, US.